{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:25:28Z","timestamp":1795119928805,"version":"4.10.3"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100819"],"award-info":[{"award-number":["82100819"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271411"],"award-info":[{"award-number":["32271411"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.biopha.2024.117185","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T17:01:55Z","timestamp":1721840515000},"page":"117185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Carboxylated mesoporous silica nanoparticle-nucleic acid chimera conjugate-assisted delivery of siRNA and doxorubicin effectively treat drug-resistant bladder cancer."],"prefix":"10.1016","volume":"178","author":[{"given":"Jintao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongwen","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0961-0329","authenticated-orcid":false,"given":"Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10364","key":"10.1016\/j.biopha.2024.117185_bib1","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","volume":"400","author":"Comperat","year":"2022","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.biopha.2024.117185_bib2","article-title":"Bladder cancer: current challenges and future directions","volume":"57","author":"Dobruch","year":"2021","journal-title":"Med. (Kaunas. )"},{"issue":"38","key":"10.1016\/j.biopha.2024.117185_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1200\/EDBK_201227","article-title":"Multidisciplinary management of muscle-invasive bladder cancer: current challenges and future directions","author":"Aragon-Ching","year":"2018","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"2","key":"10.1016\/j.biopha.2024.117185_bib4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","article-title":"Tumor evolution and drug response in patient-derived organoid models of bladder cancer","volume":"173","author":"Lee","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2024.117185_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.addr.2020.06.007","article-title":"Engineering the drug carrier biointerface to overcome biological barriers to drug delivery","volume":"167","author":"Finbloom","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"22","key":"10.1016\/j.biopha.2024.117185_bib6","article-title":"Janus nanobullets combine photodynamic therapy and magnetic hyperthermia to potentiate synergetic anti-metastatic immunotherapy","volume":"6","author":"Wang","year":"2019","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.biopha.2024.117185_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.biomaterials.2016.05.030","article-title":"Janus \"nano-bullets\" for magnetic targeting liver cancer chemotherapy","volume":"100","author":"Shao","year":"2016","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.biopha.2024.117185_bib8","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1039\/C8NR08337A","article-title":"A multifunctional mesoporous silica-gold nanocluster hybrid platform for selective breast cancer cell detection using a catalytic amplification-based colorimetric assay","volume":"11","author":"Li","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2024.117185_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122122","article-title":"Gold nanoparticles for skin drug delivery","volume":"625","author":"Chen","year":"2022","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.biopha.2024.117185_bib10","article-title":"Mesoporous silica-encapsulated gold nanorods for drug delivery\/release and two-photon excitation fluorescence imaging to guide synergistic phototherapy and chemotherapy","author":"He","year":"2023","journal-title":"ACS Appl. Bio Mater."},{"issue":"15","key":"10.1016\/j.biopha.2024.117185_bib11","doi-asserted-by":"crossref","first-page":"18630","DOI":"10.1021\/acsami.2c22860","article-title":"Enhanced and extended ophthalmic drug delivery by ph-triggered drug-eluting contact lenses with large-pore mesoporous silica nanoparticles","volume":"15","author":"Lai","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"7","key":"10.1016\/j.biopha.2024.117185_bib12","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1021\/acsnano.2c11112","article-title":"ROS-responsive janus Au\/mesoporous silica core\/shell nanoparticles for drug delivery and long-term CT imaging tracking of mscs in pulmonary fibrosis treatment","volume":"17","author":"Li","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biopha.2024.117185_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010227","article-title":"Recent advances in mesoporous silica nanoparticle-mediated drug delivery for breast cancer treatment","volume":"15","author":"Rani","year":"2023","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.biopha.2024.117185_bib14","doi-asserted-by":"crossref","first-page":"12732","DOI":"10.1021\/acsnano.7b07486","article-title":"Janus gold nanoplatform for synergetic chemoradiotherapy and computed tomography imaging of hepatocellular carcinoma","volume":"11","author":"Wang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2024.117185_bib15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.actbio.2016.11.007","article-title":"The shape effect of magnetic mesoporous silica nanoparticles on endocytosis, biocompatibility and biodistribution","volume":"49","author":"Shao","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2024.117185_bib16","article-title":"Bioinspired diselenide-bridged mesoporous silica nanoparticles for dual-responsive protein delivery","author":"Shao","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2024.117185_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.biomaterials.2017.10.047","article-title":"Shape-controlled magnetic mesoporous silica nanoparticles for magnetically-mediated suicide gene therapy of hepatocellular carcinoma","volume":"154","author":"Wang","year":"2018","journal-title":"Biomaterials"},{"issue":"13","key":"10.1016\/j.biopha.2024.117185_bib18","doi-asserted-by":"crossref","first-page":"10656","DOI":"10.1021\/acsami.7b19325","article-title":"Shape engineering boosts magnetic mesoporous silica nanoparticle-based isolation and detection of circulating tumor cells","volume":"10","author":"Chang","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"7","key":"10.1016\/j.biopha.2024.117185_bib19","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1021\/acsami.5b11310","article-title":"Janus silver-mesoporous silica nanocarriers for SERS traceable and pH-sensitive drug delivery in cancer therapy","volume":"8","author":"Shao","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2024.117185_bib20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.actbio.2019.09.034","article-title":"Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence","volume":"100","author":"Zhang","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2024.117185_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122555","article-title":"pH-responsive and targeted delivery of chrysin via folic acid-functionalized mesoporous silica nanocarrier for breast cancer therapy","volume":"631","author":"Ghosh","year":"2023","journal-title":"Int J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.117185_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jpp\/rgac028","article-title":"Targeted delivery and apoptosis induction activity of peptide-transferrin targeted mesoporous silica encapsulated resveratrol in MCF-7 cells","volume":"75","author":"Li","year":"2023","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.biopha.2024.117185_bib23","article-title":"PNA-ATP aptamer-capped doxorubicin-loaded silica nanoparticles for targeted cancer therapy","volume":"45","author":"Kazemi","year":"2022","journal-title":"Nanomedicine"},{"issue":"36","key":"10.1016\/j.biopha.2024.117185_bib24","doi-asserted-by":"crossref","first-page":"30306","DOI":"10.1021\/acsami.7b06446","article-title":"Janus silver\/silica nanoplatforms for light-activated liver cancer chemo\/photothermal therapy","volume":"9","author":"Wang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"6","key":"10.1016\/j.biopha.2024.117185_bib25","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/cbdd.12622","article-title":"Facile synthesis of core-shell magnetic mesoporous silica nanoparticles for pH-sensitive anticancer drug delivery","volume":"86","author":"Shao","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"issue":"8","key":"10.1016\/j.biopha.2024.117185_bib26","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1021\/nn100690m","article-title":"Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line","volume":"4","author":"Meng","year":"2010","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biopha.2024.117185_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00085-0","article-title":"siRNA delivery using intelligent chitosan-capped mesoporous silica nanoparticles for overcoming multidrug resistance in malignant carcinoma cells","volume":"11","author":"Heidari","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.117185_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.biomaterials.2016.07.009","article-title":"Gold nanoparticle-DNA aptamer conjugate-assisted delivery of antimicrobial peptide effectively eliminates intracellular Salmonella enterica serovar Typhimurium","volume":"104","author":"Yeom","year":"2016","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.biopha.2024.117185_bib29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.nano.2014.09.002","article-title":"Multifunctional nanoparticle-EpCAM aptamer bioconjugates: a paradigm for targeted drug delivery and imaging in cancer therapy","volume":"11","author":"Das","year":"2015","journal-title":"Nanomedicine"},{"issue":"9","key":"10.1016\/j.biopha.2024.117185_bib30","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.1560","article-title":"Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors","volume":"27","author":"Dassie","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2024.117185_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-4939-2432-5_11","article-title":"Aptamer-siRNA chimeras for HIV","author":"Takahashi","year":"2015","journal-title":"Adv. Exp. Med Biol. 848"},{"issue":"3","key":"10.1016\/j.biopha.2024.117185_bib32","article-title":"Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles","volume":"11","author":"Sivakumar","year":"2019","journal-title":"Wiley Inter. Rev. Nanomed. Nanobiotechnol"},{"key":"10.1016\/j.biopha.2024.117185_bib33","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.actbio.2021.07.023","article-title":"Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs","volume":"134","author":"Gou","year":"2021","journal-title":"Acta Biomater."},{"issue":"6","key":"10.1016\/j.biopha.2024.117185_bib34","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1158\/0008-5472.CAN-21-2691","article-title":"Development of novel aptamer-based targeted chemotherapy for bladder cancer","volume":"82","author":"Wang","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2024.117185_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109139","article-title":"Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT\/mTOR and p38 signaling pathways","volume":"121","author":"Wei","year":"2020","journal-title":"Biomed. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2024.117185_bib36","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/jb\/mvaa009","article-title":"Overexpression of RSK4 reverses doxorubicin resistance in human breast cancer cells via PI3K\/AKT signalling pathway","volume":"167","author":"Mei","year":"2020","journal-title":"J. Biochem"},{"issue":"1","key":"10.1016\/j.biopha.2024.117185_bib37","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/acs.jnatprod.1c00950","article-title":"Salidroside promotes sensitization to doxorubicin in human cancer cells by affecting the PI3K\/Akt\/HIF signal pathway and inhibiting the expression of tumor-resistance-related proteins","volume":"85","author":"Zeng","year":"2022","journal-title":"J. Nat. Prod."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224010692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224010692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:26:03Z","timestamp":1778545563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224010692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":37,"alternative-id":["S0753332224010692"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117185","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carboxylated mesoporous silica nanoparticle-nucleic acid chimera conjugate-assisted delivery of siRNA and doxorubicin effectively treat drug-resistant bladder cancer.","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117185"}}